If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenold Regulatory News (RNO)

  • This share is currently suspended. It was suspended at a price of 81.80
  • There is currently no data for RNO

Trading Update

1 May 2013 07:00

RNS Number : 7043D
Renold PLC
01 May 2013
 



Renold plc

("Renold", "the Company" or "the Group")

 

Trading Update

 

Renold, a leading international supplier of industrial chains and related power transmission products, today issues a trading update ahead of its full year results for the year ended 31st March 2013, which will be announced on 28th May 2013.

 

Trading

Challenging conditions across all end markets persisted throughout the year and underlying revenue for the full year ended down 7% compared to the prior year. Group underlying second half revenue was 4% lower than the first half. The impact of the revenue reduction in the second half was fully offset by management action to reduce ongoing overheads. As a result, adjusted operating profit in the second half was in line with the first half and the full year adjusted operating profit is therefore in line with market expectations.

 

Working capital and debt

Working capital and capital expenditure were closely managed during the second half. This resulted in net cash generation in the second half, whilst at the year end net debt closed below the position at the start of the year.

 

During March, the Group agreed a new funding plan and merger of the UK defined benefit pension plans which is expected to reduce annual cash costs by £1.0m. In addition, since the year end, the Group completed the process of winding up the pension fund surplus in South Africa. A pre-tax cash surplus of £1.3m was returned to the Group in April 2013 with a further £0.1m outstanding.

 

Robert Purcell, Chief Executive of Renold plc, said:

"We are pleased with a good improvement in book to bill ratios in the second half versus the prior year. However, with trading conditions expected to remain challenging, we are developing plans to lower the Group's breakeven point and further improve our commercial position, and I look forward to reporting in further detail at the full year results announcement in May. The business remains focussed on delivering sustainable cash generation which has been enhanced by the recent progress on UK and South African pension schemes."

 

 

\* The use of "underlying" excludes the impact of changes in foreign exchange rates. "Adjusted" excludes the impact of exceptional items.

 

1 May 2013

 

 

ENQUIRIES:

 

Renold plc

0161 498 4500

Robert Purcell, Chief Executive

Brian Tenner, Finance Director

Arden Partners

020 7614 5917

Chris Hardie

College Hill

020 7457 2020

Mark Garraway

Helen Tarbet

 

  

NOTES FOR EDITORS

 

Renold is a global leader in the manufacture of industrial chains and also manufactures a range of torque transmission products which are sold throughout the world to a broad range of original equipment manufacturers and distributors. The Company has a well deserved reputation for quality that is recognised worldwide. Its products are used in a wide variety of industries including manufacturing, transportation, energy, steel and mining.

 

Further information about Renold can be found on the website at: www.renold.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLIFSEEFILIIV
Date   Source Headline
8th May 20132:27 pmRNSHolding(s) in Company
2nd May 20135:47 pmRNSNotification of major interest in shares
2nd May 20134:40 pmRNSSecond Price Monitoring Extn
2nd May 20134:35 pmRNSPrice Monitoring Extension
1st May 20134:40 pmRNSSecond Price Monitoring Extn
1st May 20134:35 pmRNSPrice Monitoring Extension
1st May 20137:00 amRNSTrading Update
10th Apr 20134:35 pmRNSPrice Monitoring Extension
28th Mar 20135:09 pmRNSDirector/PDMR Shareholding
26th Mar 20132:45 pmRNSRe: Pensions Scheme
27th Feb 20137:00 amRNSDirector/PDMR Shareholding
14th Feb 20137:00 amRNSInterim Management Statement
30th Jan 201311:02 amRNSDirector/PDMR Shareholding
21st Jan 20135:08 pmRNSDirector/PDMR Shareholding
21st Jan 201312:31 pmRNSDirectorate Matters
31st Dec 201212:40 pmRNSSecond Price Monitoring Extn
31st Dec 201212:35 pmRNSPrice Monitoring Extension
21st Dec 20127:00 amRNSRe. Directorate Appointment
19th Dec 20124:41 pmRNSSecond Price Monitoring Extn
19th Dec 20124:35 pmRNSPrice Monitoring Extension
10th Dec 20124:40 pmRNSSecond Price Monitoring Extn
10th Dec 20124:35 pmRNSPrice Monitoring Extension
3rd Dec 20122:14 pmRNSHolding(s) in Company
28th Nov 20127:00 amRNSDirector/PDMR Shareholding
26th Nov 20121:47 pmRNSNotification of major interest in shares
26th Nov 20121:03 pmRNSDirector/PDMR Shareholding
20th Nov 20127:00 amRNSHalf Yearly Report
12th Nov 20124:40 pmRNSSecond Price Monitoring Extn
12th Nov 20124:35 pmRNSPrice Monitoring Extension
26th Oct 20127:00 amRNSDirector Declaration
10th Oct 20124:40 pmRNSSecond Price Monitoring Extn
10th Oct 20124:35 pmRNSPrice Monitoring Extension
4th Oct 20127:00 amRNSNew Bank Facilities & Trading Update
21st Sep 20124:05 pmRNSHolding(s) in Company
7th Aug 20129:55 amRNSDirector/PDMR Shareholding
2nd Aug 20127:00 amRNSInterim Management Statement
1st Aug 20127:01 amRNSBlocklisting Interim Review
1st Aug 20127:00 amRNSBlocklisting Interim Review
16th Jul 20124:40 pmRNSSecond Price Monitoring Extn
16th Jul 20124:35 pmRNSPrice Monitoring Extension
12th Jul 20123:44 pmRNSResult of AGM
6th Jul 20125:07 pmRNSAnnual Report and Accounts
8th Jun 20123:41 pmRNSDirector/PDMR Shareholding
6th Jun 20127:00 amRNSDirector/PDMR Shareholding
31st May 20121:33 pmRNSDirector/PDMR Shareholding
31st May 20121:33 pmRNSDirector/PDMR Shareholding
29th May 20127:00 amRNSFinal Results
23rd May 20124:40 pmRNSSecond Price Monitoring Extn
23rd May 20124:35 pmRNSPrice Monitoring Extension
23rd May 201210:14 amRNSReplacement- Exercise of Share Warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.